-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Eddie AM; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and School of Medicine, Nashville TN., Chen KW; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and School of Medicine, Nashville TN., Schenkel LB; Ribon Therapeutics, Cambridge, MA., Swinger KK; Ribon Therapeutics, Cambridge, MA., Molina JR; Ribon Therapeutics, Cambridge, MA., Kunii K; Ribon Therapeutics, Cambridge, MA., Raybuck AL; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and School of Medicine, Nashville TN., Keilhack H; Ribon Therapeutics, Cambridge, MA., Gibson-Corley KN; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and School of Medicine, Nashville TN., Niepel M; Ribon Therapeutics, Cambridge, MA., Peebles RS; Department of Medicine, Vanderbilt University Medical Center and School of Medicine, Nashville TN; and.; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville Campus, Nashville TN., Boothby MR; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and School of Medicine, Nashville TN; mark.boothby@vumc.org., Cho SH; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and School of Medicine, Nashville TN.
المصدر: ImmunoHorizons [Immunohorizons] 2022 Jul 11; Vol. 6 (7), pp. 432-446. Date of Electronic Publication: 2022 Jul 11.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association of Immunologists, Inc Country of Publication: United States NLM ID: 101708159 Publication Model: Electronic Cited Medium: Internet ISSN: 2573-7732 (Electronic) Linking ISSN: 25737732 NLM ISO Abbreviation: Immunohorizons Subsets: MEDLINE
مواضيع طبية MeSH: Allergens* , Asthma*/drug therapy, Animals ; Disease Models, Animal ; Immunoglobulin E ; Mice ; Mucus/metabolism ; Pharmaceutical Preparations/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Poly(ADP-ribose) Polymerases/genetics ; Poly(ADP-ribose) Polymerases/metabolism ; Poly(ADP-ribose) Polymerases/therapeutic use
-
5دورية أكاديمية
المؤلفون: Gozgit JM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA. Electronic address: jgozgit@ribontx.com., Vasbinder MM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Abo RP; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Kunii K; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Kuplast-Barr KG; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Gui B; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Lu AZ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Molina JR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Minissale E; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Swinger KK; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Wigle TJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Blackwell DJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Majer CR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Ren Y; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Niepel M; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Varsamis ZA; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Nayak SP; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Bamberg E; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Mo JR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Church WD; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Mady ASA; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Song J; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Utley L; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Rao PE; Patricia E. Rao Consulting, Acton, MA 01720, USA., Mitchison TJ; Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Warren Alpert 536, Boston, MA 02115, USA., Kuntz KW; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Richon VM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Keilhack H; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA. Electronic address: hkeilhack@ribontx.com.
المصدر: Cancer cell [Cancer Cell] 2021 Sep 13; Vol. 39 (9), pp. 1214-1226.e10. Date of Electronic Publication: 2021 Jul 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
مواضيع طبية MeSH: Drug Resistance, Neoplasm/*drug effects , Interferon Type I/*metabolism , Neoplasms/*drug therapy , Nucleoside Transport Proteins/*genetics , Nucleoside Transport Proteins/*metabolism , Small Molecule Libraries/*administration & dosage, Adaptive Immunity/drug effects ; Animals ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; HEK293 Cells ; HeLa Cells ; Humans ; Mice ; Neoplasms/genetics ; Neoplasms/metabolism ; Signal Transduction/drug effects ; Small Molecule Libraries/pharmacology ; Tumor Escape/drug effects ; Xenograft Model Antitumor Assays
-
6دورية أكاديمية
المؤلفون: Schenkel LB; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; MOMA Therapeutics, Cambridge, MA 02142, USA., Molina JR; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Swinger KK; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Xilio Therapeutics, Waltham, MA 02451, USA., Abo R; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Obsidian Therapeutics, Cambridge, MA 02138, USA., Blackwell DJ; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Lu AZ; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Cheung AE; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; A2Empowerment, Arlington, MA 02474, USA., Church WD; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Kunii K; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Kuplast-Barr KG; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Majer CR; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Minissale E; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Mo JR; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Niepel M; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Reik C; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Bain & Company, Boston, MA 02116, USA., Ren Y; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Vasbinder MM; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Wigle TJ; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Richon VM; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Keilhack H; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Kuntz KW; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA. Electronic address: kkuntz@ribontx.com.
المصدر: Cell chemical biology [Cell Chem Biol] 2021 Aug 19; Vol. 28 (8), pp. 1158-1168.e13. Date of Electronic Publication: 2021 Mar 10.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Inflammation/*drug therapy , Interleukin-4/*antagonists & inhibitors , Kidney Neoplasms/*drug therapy , Macrophages/*drug effects , Poly(ADP-ribose) Polymerases/*metabolism, Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Dose-Response Relationship, Drug ; Female ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/genetics ; HEK293 Cells ; Humans ; Inflammation/genetics ; Inflammation/metabolism ; Interleukin-4/genetics ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; Macrophages/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Models, Molecular ; Molecular Structure ; Poly(ADP-ribose) Polymerases/genetics ; RAW 264.7 Cells ; RNA, Messenger/drug effects ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
-
7دورية أكاديمية
المؤلفون: Wigle TJ; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Ren Y; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Molina JR; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Blackwell DJ; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Schenkel LB; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Swinger KK; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Kuplast-Barr K; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Majer CR; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Church WD; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Lu AZ; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Mo J; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Abo R; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Cheung A; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Dorsey BW; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Niepel M; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Perl NR; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Vasbinder MM; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Keilhack H; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Kuntz KW; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA.
المصدر: Chembiochem : a European journal of chemical biology [Chembiochem] 2021 Jun 15; Vol. 22 (12), pp. 2107-2110. Date of Electronic Publication: 2021 May 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Wigle TJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA. Electronic address: twigle@ribontx.com., Blackwell DJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Schenkel LB; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Ren Y; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Church WD; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Desai HJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Swinger KK; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Santospago AG; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Majer CR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Lu AZ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Niepel M; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Perl NR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Vasbinder MM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Keilhack H; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Kuntz KW; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA.
المصدر: Cell chemical biology [Cell Chem Biol] 2020 Jul 16; Vol. 27 (7), pp. 877-887.e14.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE
مواضيع طبية MeSH: Fluorescent Dyes/*chemistry , Poly(ADP-ribose) Polymerase Inhibitors/*chemistry , Poly(ADP-ribose) Polymerases/*metabolism, Binding, Competitive ; Fluorescence Resonance Energy Transfer ; Fluorescent Dyes/chemical synthesis ; Fluorescent Dyes/metabolism ; HEK293 Cells ; Humans ; Isoenzymes/antagonists & inhibitors ; Isoenzymes/genetics ; Isoenzymes/metabolism ; Kinetics ; NAD/chemistry ; NAD/metabolism ; Nanoparticles/chemistry ; Poly(ADP-ribose) Polymerase Inhibitors/chemical synthesis ; Poly(ADP-ribose) Polymerase Inhibitors/metabolism ; Poly(ADP-ribose) Polymerases/chemistry ; Poly(ADP-ribose) Polymerases/genetics ; Protein Binding ; Recombinant Proteins/biosynthesis ; Recombinant Proteins/isolation & purification ; Recombinant Proteins/metabolism ; Surface Plasmon Resonance
-
9دورية أكاديمية
المؤلفون: Wigle TJ; Ribon Therapeutics Inc., Cambridge, MA, USA., Church WD; Ribon Therapeutics Inc., Cambridge, MA, USA., Majer CR; Ribon Therapeutics Inc., Cambridge, MA, USA., Swinger KK; Ribon Therapeutics Inc., Cambridge, MA, USA., Aybar D; Ribon Therapeutics Inc., Cambridge, MA, USA., Schenkel LB; Ribon Therapeutics Inc., Cambridge, MA, USA., Vasbinder MM; Ribon Therapeutics Inc., Cambridge, MA, USA., Brendes A; Evotec SE, Hamburg, Germany., Beck C; Evotec SE, Hamburg, Germany., Prahm M; Evotec SE, Hamburg, Germany., Wegener D; Evotec SE, Hamburg, Germany., Chang P; Ribon Therapeutics Inc., Cambridge, MA, USA., Kuntz KW; Ribon Therapeutics Inc., Cambridge, MA, USA.
المصدر: SLAS discovery : advancing life sciences R & D [SLAS Discov] 2020 Mar; Vol. 25 (3), pp. 241-252. Date of Electronic Publication: 2019 Dec 19.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101697563 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2472-5560 (Electronic) Linking ISSN: 24725552 NLM ISO Abbreviation: SLAS Discov Subsets: MEDLINE
مواضيع طبية MeSH: High-Throughput Screening Assays*, ADP Ribose Transferases/*antagonists & inhibitors , Enzyme Inhibitors/*isolation & purification , Poly(ADP-ribose) Polymerase Inhibitors/*isolation & purification , Protein Processing, Post-Translational/*genetics, ADP Ribose Transferases/chemistry ; ADP Ribose Transferases/genetics ; ADP-Ribosylation/genetics ; Adenosine Diphosphate Ribose/genetics ; Enzyme Inhibitors/pharmacology ; Humans ; NAD/chemistry ; Poly ADP Ribosylation/genetics ; Poly(ADP-ribose) Polymerase Inhibitors/chemistry ; Poly(ADP-ribose) Polymerases/drug effects ; Poly(ADP-ribose) Polymerases/genetics ; Substrate Specificity
-
10دورية أكاديمية
المؤلفون: Morrison MJ; Epizyme Inc., Cambridge, Massachusetts, United States of America., Boriack-Sjodin PA; Epizyme Inc., Cambridge, Massachusetts, United States of America., Swinger KK; Epizyme Inc., Cambridge, Massachusetts, United States of America., Wigle TJ; Epizyme Inc., Cambridge, Massachusetts, United States of America., Sadalge D; Epizyme Inc., Cambridge, Massachusetts, United States of America., Kuntz KW; Epizyme Inc., Cambridge, Massachusetts, United States of America., Scott MP; Epizyme Inc., Cambridge, Massachusetts, United States of America., Janzen WP; Epizyme Inc., Cambridge, Massachusetts, United States of America., Chesworth R; Epizyme Inc., Cambridge, Massachusetts, United States of America., Duncan KW; Epizyme Inc., Cambridge, Massachusetts, United States of America., Harvey DM; Epizyme Inc., Cambridge, Massachusetts, United States of America., Lampe JW; Epizyme Inc., Cambridge, Massachusetts, United States of America., Mitchell LH; Epizyme Inc., Cambridge, Massachusetts, United States of America., Copeland RA; Epizyme Inc., Cambridge, Massachusetts, United States of America.
المصدر: PloS one [PLoS One] 2018 May 09; Vol. 13 (5), pp. e0197082. Date of Electronic Publication: 2018 May 09 (Print Publication: 2018).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
مواضيع طبية MeSH: Enzyme Inhibitors/*chemistry , Histone-Lysine N-Methyltransferase/*antagonists & inhibitors , Neoplasms/*drug therapy , Peptides/*chemistry , Repressor Proteins/*antagonists & inhibitors, Crystallography, X-Ray ; Enzyme Inhibitors/pharmacology ; Histone-Lysine N-Methyltransferase/chemistry ; Histone-Lysine N-Methyltransferase/genetics ; Histones/chemistry ; Histones/genetics ; Humans ; Lysine/chemistry ; Neoplasms/enzymology ; Norleucine/analogs & derivatives ; Norleucine/chemistry ; Norleucine/pharmacology ; PR-SET Domains/genetics ; Peptides/genetics ; Protein Conformation/drug effects ; Repressor Proteins/chemistry ; Repressor Proteins/genetics